Epitope insertion into variable loops of HIV-1 gp120 as a potential means to improve immunogenicity of viral envelope protein

By Liang X.   Munshi S.   Shendure J.   Mark G.   Davies M.E.   Freed D.C.   Montefiori D.C.   Shiver J.W.  

Vaccine, Vol. 17, Iss. 22, 1999-07 ,pp. : 2862-2872

Elsevier

Access to resources Recommend Favorite

Recombinant gp160 vaccination schedule and MHC HLA type as factors influencing cellular responses to HIV-1 envelope glycoprotein

By Gorse G.J.   Patel G.B.   Newman F.K.   Mandava M.   Belshe R.B.  

Vaccine, Vol. 13, Iss. 13, 1995-01 ,pp. : 1170-1179

Elsevier

Access to resources Recommend Favorite

Construction and immunogenicity of Salmonella typhimurium vaccine vectors that express HIV-1 gp120

By Fouts T.R.   Tuskan R.G.   Chada S.   Hone D.M.   Lewis G.K.  

Vaccine, Vol. 13, Iss. 17, 1995-12 ,pp. : 1697-1705

Elsevier

Access to resources Recommend Favorite

HIV-1 envelope protein gp120 triggers a Th2 response in mice that shifts to Th1 in the presence of human growth hormone

By Mellado M.   Llorente M.   Rodriguez-Frade J.M.   Lucas P.   Martinez-A C.   del Real G.  

Vaccine, Vol. 16, Iss. 11, 1998-07 ,pp. : 1111-1115

Elsevier

Access to resources Recommend Favorite

Efficient purification and rigorous characterisation of a recombinant gp120 for HIV vaccine studies

By Jones D.H.   McBride B.W.   Roff M.A.   Farrar G.H.  

Vaccine, Vol. 13, Iss. 11, 1995-01 ,pp. : 991-999

Elsevier

Access to resources Recommend Favorite